Felixvet is a leading global veterinary pharmaceutical company headquartered in Dublin, dedicated to enhancing the health and wellbeing of companion animals worldwide. Specializing in the development, manufacturing, and marketing of high-quality pharmaceutical products, Felixvet offers a diverse portfolio that includes conventional generics, value-added, and complex generics, with over 65 products currently at various stages of development or approval by the US FDA.

Their mission is to deliver cost-effective, bio-equivalent solutions tailored for both veterinarians and pet owners, thereby ensuring optimal care for pets. With a strong commitment to research and innovation, Felixvet stands as a trusted partner to leading animal health companies, fostering growth and excellence in veterinary medicine.

Backed by a passionate team of over 300 industry professionals, Felixvet is well-equipped to navigate the challenges of the veterinary market, ensuring their products not only meet but exceed expectations. Their extensive manufacturing capabilities and ongoing dedication to pet welfare affirm their position as a pioneer in the veterinary pharmaceutical landscape.